X

    XPH (XPH)

    Sector Equity • Pharmaceuticals

    $70.70
    -0.09 (-0.13%)

    Market Cap: $287.80M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Dividends

    Dividend Metrics

    Yield0.47%
    Annual/Share$0.34
    Frequency4
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR-11.55%
    5Y CAGR+13.71%
    View XPH's full dividend history

    XPH (XPH)

    Pharmaceuticals • USA

    Net Assets (AUM)$287.80M
    Expense Ratio0.3500%
    Dividend Yield0.48%
    Portfolio Turnover45.00%
    Inception DateJun 19, 2006

    Sector Allocations

    Healthcare99.9%
    Communication Services0.0%
    Consumer Discretionary0.0%
    Consumer Staples0.0%
    Energy0.0%
    Financials0.0%
    Industrials0.0%
    Information Technology0.0%
    Materials0.0%
    Real Estate0.0%
    Utilities0.0%

    Technical Indicators

    RSI: Neutral
    RSI (14)50.59
    VWAP
    $70.510

    Simple Moving Averages

    SMA 10
    $72.46
    SMA 20
    $71.31
    SMA 50
    $68.94
    SMA 200
    $59.33

    Exponential Moving Averages

    EMA 10
    $71.77
    EMA 20
    $71.17
    EMA 50
    $68.48
    EMA 200
    $59.99

    Holdings (64)

    Holdings as of Aug 30, 2026
    Rank
    Symbol
    Name
    Weight
    1AMLXAMYLYX PHARMACEUTICALS INC3.89%
    2CRNXCRINETICS PHARMACEUTICALS INC3.49%
    3MBXMBX BIOSCIENCES INC3.04%
    4ATAIATAIBECKLEY INC2.76%
    5DFTXn/a2.66%
    6OMEROMEROS CORP2.52%
    7ELVNENLIVEN THERAPEUTICS INC2.33%
    8CORTCORCEPT THERAPEUTICS INC2.17%
    9NUVBn/a2.15%
    10ETONETON PHARMACEUTICALS INC2.09%
    11EWTXEDGEWISE THERAPEUTICS INC1.91%
    12TRVITREVI THERAPEUTICS INC1.89%
    13PRGOPERRIGO CO PLC1.87%
    14NKTRNEKTAR THERAPEUTICS1.84%
    15MRKMERCK & CO INC1.82%
    16OCULOCULAR THERAPEUTIX INC1.74%
    17BMYBRISTOL-MYERS SQUIBB CO1.72%
    18MAZEMAZE THERAPEUTICS INC1.70%
    19RAPPRAPPORT THERAPEUTICS INC1.68%
    20AMRXn/a1.66%
    21ALMSALUMIS INC1.66%
    22LGNDLIGAND PHARMACEUTICALS INC1.64%
    23TARSn/a1.63%
    24RPRXROYALTY PHARMA PLC CLASS A1.60%
    25JNJJOHNSON & JOHNSON1.60%
    Showing 1-25 of 64
    Show:
    Page 1 of 3

    Related GNG Research

    No research available

    Be the first to write about XPH

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.